Skip to main content

Table 1 Drug likeness and pharmacokinetic properties of AGP derivatives

From: Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach

Compounds

MW

logP

HBA

HBD

Rotatable bond

TPSA

BBB permeant

GI Absorption

BA scores

1 AGP

350.45

1.96

5

3

3

86.99

No

High

0.55

2

482.57

3.23

7

3

4

105.45

No

High

0.55

3

484.58

3.21

7

4

5

116.45

No

High

0.55

4

454.56

3.21

6

4

4

107.22

No

High

0.55

5

470.56

2.91

7

5

4

127.45

No

High

0.55

6

483.55

3.93

7

3

5

132.81

No

Low

0.55

7

473.00

4.15

5

3

4

86.99

No

High

0.55

8

524.43

4.52

7

2

6

105.95

No

High

0.55

9

470.55

3.88

7

3

6

113.29

No

High

0.55

10

482.50

4.45

7

1

3

83.47

No

High

0.55

11

484.59

4.44

7

2

4

94.46

No

High

0.55

12

454.56

4.43

6

2

3

85.23

No

High

0.55

13

470.56

4.13

7

3

3

105.46

No

High

0.55

14

483.56

5.16

7

1

4

110.83

No

High

0.55

15

473.01

5.38

5

1

3

65.00

Yes

High

0.55

16

547.67

4.87

8

3

8

147.61

No

Low

0.55

17

470.56

3.53

7

3

6

113.29

No

High

0.55

REM

602.58

3.28

12

4

14

213.36

No

Low

0.17

HCQ

335.87

3.35

3

2

9

48.39

yes

High

0.55

  1. MW molecular weight, HBA hydrogen bond acceptor, HBD hydrogen bond donor, TPSA topological polar surface area, AGP andrographolide, REM remdesivir, HCQ hydroxychloroquine